Statistical analysis indicated no alterations in fibronectin mRNA expression levels within the SC (p = 0.990; Figure 12A) and the OL (p = 0.601; Figure 12A), but enhanced within the MC (p = 0.041; Figure 12A) of ALS patients compared to healthy controls. The gene discussed is FN1; the disease is amyotrophic lateral sclerosis.